SMO Clinplus Co (SZSE:301257) Accounts Payable & Accrued Expense : ¥94.3 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is SMO Clinplus Co Accounts Payable & Accrued Expense?

SMO Clinplus Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥84.0 Mil) to Dec. 2023 (¥103.3 Mil) but then declined from Dec. 2023 (¥103.3 Mil) to Mar. 2024 (¥94.3 Mil).

SMO Clinplus Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥69.4 Mil) to Dec. 2022 (¥79.9 Mil) and increased from Dec. 2022 (¥79.9 Mil) to Dec. 2023 (¥103.3 Mil).

SMO Clinplus Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for SMO Clinplus Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMO Clinplus Co Accounts Payable & Accrued Expense Chart

SMO Clinplus Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

31.62

36.39

69.40

79.91

103.29

SMO Clinplus Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															70.39	100.14	83.99	103.29	94.28

SMO Clinplus Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

SMO Clinplus Co (SZSE:301257) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SMO Clinplus Co Ltd (SZSE:301257) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 105 Sinan Road, Room 108, Building 1, Huangpu District, Shanghai, CHN, 200001

Website

http://www.smo-clinplus.com

SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.

Executives

Lai Chun Bao	Director
Ma Lin	Director

SMO Clinplus Co (SZSE:301257) Headlines

No Headlines